好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

An Uncommon Case of Treatment-Responsive SSPE
Infectious Disease
P4 - Poster Session 4 (5:30 PM-6:30 PM)
4-021

To describe a case of SSPE with successful response to long-term treatment.

While neurologic manifestations of SSPE are well described, reports of long-term response to treatment are extremely rare.

Medical charts and literature pertinent to SSPE and associated treatments were reviewed.

A 27-year-old man presented to the outpatient clinic to establish routine neurologic care. He has a history of measles infection at age 4 months with full clinical resolution. At age 9, he developed encephalitis which manifested with frequent seizures, imbalance, left hemiparesis, and falls. His neurologic exam deteriorated rapidly over 6 months. He exhibited severe cognitive and language impairment, and was completely wheelchair-dependent due to left hemiplegia. Laboratory testing revealed a 1:16 CSF and 1:256 serum measles titer with a positive measles IgG index. A diagnosis of SSPE was made and he was initiated on combination therapy with daily oral isoprinosine and intrathecal interferon-α every two weeks.

 

The patient demonstrated marked clinical improvement throughout the first 4 years and has since plateaued. He has residual mild cognitive and language impairment, but is independent in activities of daily living. He has persistent mild left hemiparesis but does not require any gait assistance. His epilepsy is well-controlled on lacosamide and medical cannabis in addition to vagal nerve stimulation.

Due to recent declines in childhood immunizations, there has been a reemergence of measles in the general population. The 5-year mortality rate for SSPE ranges from 95-99%. Previously thought to be incurable, there are several case reports and small studies which demonstrate notable clinical response to oral isoprinosine and intrathecal interferon-α. Although rare, neurologists should be aware of the neurologic manifestations of the measles virus and the potential treatment options.

Authors/Disclosures
Kate W. Hocquard, MD (Olmsted Medical Center)
PRESENTER
No disclosure on file
Stephen W. English, MD (Mayo Clinic) Dr. English has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainomix.
Cheolsu Shin, MD (Mayo Clinic) No disclosure on file